List of works - Robert F Hobbs

(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy

scientific article published on 26 May 2016

124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparison

scientific article

A Treatment Planning Method for Sequentially Combining Radiopharmaceutical Therapy and External Radiation Therapy ⬇️

scientific article published on October 13, 2010

A bone marrow toxicity model for ²²³Ra alpha-emitter radiopharmaceutical therapy.

scientific article

A gamma camera count rate saturation correction method for whole-body planar imaging

scientific article

A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy ⬇️

scientific article published on June 1, 2011

A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry ⬇️

scientific article published on June 15, 2012

An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer

scientific article published on October 2008

Arterial wall dosimetry for non-Hodgkin lymphoma patients treated with radioimmunotherapy

scientific article

Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen

scientific article

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors

scientific article published on 07 September 2008

Calculation of the biological effective dose for piecewise defined dose-rate fits

scientific article published on March 2009

Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent

scientific article published on 19 February 2018

Comparative Dosimetry for 68Ga-DOTATATE: Impact of using Updated ICRP phantoms, S values and Tissue Weighting Factors

scientific article published on 9 February 2018

Comparison of quantitative Y-90 SPECT and non-time-of-flight PET imaging in post-therapy radioembolization of liver cancer

scientific article

Depth-dependent concentrations of hematopoietic stem cells in the adult skeleton: Implications for active marrow dosimetry.

scientific article

Development and evaluation of convergent and accelerated penalized SPECT image reconstruction methods for improved dose-volume histogram estimation in radiopharmaceutical therapy

scientific article

Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma

scientific article

Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides.

scientific article published on 26 April 2018

Estimates of radiation-absorbed dose to kidneys in patients treated with 90Y-ibritumomab tiuxetan

scientific article

Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry

scientific article

Factors affecting the stability and repeatability of gamma camera calibration for quantitative imaging applications based on a retrospective review of clinical data

scientific article

Fine-Resolution Voxel S Values for Constructing Absorbed Dose Distributions at Variable Voxel Size ⬇️

scientific article published on September 16, 2010

Human Biodistribution and Radiation Dosimetry of 82Rb ⬇️

scientific article published on September 16, 2010

Improved dose-volume histogram estimates for radiopharmaceutical therapy by optimizing quantitative SPECT reconstruction parameters

scientific article published on 7 May 2013

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy

scientific article published on 15 October 2015

Modelling and Dosimetry for Alpha-Particle Therapy ⬇️

scientific article published on July 1, 2011

Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model

scientific article published on 18 July 2017

Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates

scientific article published on 26 February 2015

Predicting hematologic toxicity in patients undergoing radioimmunotherapy with 90Y-ibritumomab tiuxetan or 131I-tositumomab ⬇️

scientific article published on December 1, 2010

Quantitative impact of changes in marrow cellularity, skeletal size, and bone mineral density on active marrow dosimetry based upon a reference model.

scientific article published in January 2017

Radiobiologic optimization of combination radiopharmaceutical therapy applied to myeloablative treatment of non-Hodgkin lymphoma

scientific article published on 5 August 2013

Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.

scientific article

Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in 124I PET/CT-Based Dosimetry for 131I Therapy of Metastatic Differentiated Thyroid Cancer

scientific article published on 19 January 2017

Redefining Relative Biological Effectiveness in the Context of the EQDX Formalism: Implications for Alpha-Particle Emitter Therapy.

scientific article

Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy

scientific article published on January 2014

Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry

scientific article

Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.

scientific article

Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma

scientific article

Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibody

scientific article published on 19 July 2013

Three-dimensional imaging-based radiobiological dosimetry

scientific article published on September 2008

Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry

scientific article published on 15 May 2007

Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer ⬇️

scientific article published on April 12, 2011

Three‐dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy ⬇️

scientific article published on October 1, 2012

Tumor Dosimetry and Response for 153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Therapy of High-Risk Osteosarcoma ⬇️

scientific article published on January 17, 2012

List of works by Robert F Hobbs

(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy

124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparison

A Treatment Planning Method for Sequentially Combining Radiopharmaceutical Therapy and External Radiation Therapy ⬇️

A bone marrow toxicity model for ²²³Ra alpha-emitter radiopharmaceutical therapy.

A gamma camera count rate saturation correction method for whole-body planar imaging

A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy ⬇️

A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry ⬇️

An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer

Arterial wall dosimetry for non-Hodgkin lymphoma patients treated with radioimmunotherapy

Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors

Calculation of the biological effective dose for piecewise defined dose-rate fits

Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent

Comparative Dosimetry for 68Ga-DOTATATE: Impact of using Updated ICRP phantoms, S values and Tissue Weighting Factors

Comparison of quantitative Y-90 SPECT and non-time-of-flight PET imaging in post-therapy radioembolization of liver cancer

Depth-dependent concentrations of hematopoietic stem cells in the adult skeleton: Implications for active marrow dosimetry.

Development and evaluation of convergent and accelerated penalized SPECT image reconstruction methods for improved dose-volume histogram estimation in radiopharmaceutical therapy

Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma

Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides.

Estimates of radiation-absorbed dose to kidneys in patients treated with 90Y-ibritumomab tiuxetan

Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry

Factors affecting the stability and repeatability of gamma camera calibration for quantitative imaging applications based on a retrospective review of clinical data

Fine-Resolution Voxel S Values for Constructing Absorbed Dose Distributions at Variable Voxel Size ⬇️

Human Biodistribution and Radiation Dosimetry of 82Rb ⬇️

Improved dose-volume histogram estimates for radiopharmaceutical therapy by optimizing quantitative SPECT reconstruction parameters

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy

Modelling and Dosimetry for Alpha-Particle Therapy ⬇️

Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model

Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates

Predicting hematologic toxicity in patients undergoing radioimmunotherapy with 90Y-ibritumomab tiuxetan or 131I-tositumomab ⬇️

Quantitative impact of changes in marrow cellularity, skeletal size, and bone mineral density on active marrow dosimetry based upon a reference model.

Radiobiologic optimization of combination radiopharmaceutical therapy applied to myeloablative treatment of non-Hodgkin lymphoma

Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.

Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in 124I PET/CT-Based Dosimetry for 131I Therapy of Metastatic Differentiated Thyroid Cancer

Redefining Relative Biological Effectiveness in the Context of the EQDX Formalism: Implications for Alpha-Particle Emitter Therapy.

Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy

Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry

Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.

Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma

Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibody

Three-dimensional imaging-based radiobiological dosimetry

Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry

Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer ⬇️

Three‐dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy ⬇️

Tumor Dosimetry and Response for 153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Therapy of High-Risk Osteosarcoma ⬇️